Josef Finsterer1, Marlies Frank2. 1. Krankenanstalt Rudolfstiftung, Austria. 2. First Medical Department, Krankenanstalt Rudolfstiftung, Austria.
Abstract
INTRODUCTION: This study aimed to assess the kind of haematological abnormalities that are present in patients with mitochondrial disorders (MIDs) and the frequency of their occurrence. METHODS: The blood cell counts of a cohort of patients with syndromic and non-syndromic MIDs were retrospectively reviewed. MIDs were classified as 'definite', 'probable' or 'possible' according to clinical presentation, instrumental findings, immunohistological findings on muscle biopsy, biochemical abnormalities of the respiratory chain and/or the results of genetic studies. Patients who had medical conditions other than MID that account for the haematological abnormalities were excluded. RESULTS: A total of 46 patients ('definite' = 5; 'probable' = 9; 'possible' = 32) had haematological abnormalities attributable to MIDs. The most frequent haematological abnormality in patients with MIDs was anaemia. 27 patients had anaemia as their sole haematological problem. Anaemia was associated with thrombopenia (n = 4), thrombocytosis (n = 2), leucopenia (n = 2), and eosinophilia (n = 1). Anaemia was hypochromic and normocytic in 27 patients, hypochromic and microcytic in six patients, hyperchromic and macrocytic in two patients, and normochromic and microcytic in one patient. Among the 46 patients with a mitochondrial haematological abnormality, 78.3% had anaemia, 13.0% had thrombopenia, 8.7% had leucopenia and 8.7% had eosinophilia, alone or in combination with other haematological abnormalities. CONCLUSION: MID should be considered if a patient's abnormal blood cell counts (particularly those associated with anaemia, thrombopenia, leucopenia or eosinophilia) cannot be explained by established causes. Abnormal blood cell counts may be the sole manifestation of MID or a collateral feature of a multisystem problem.
INTRODUCTION: This study aimed to assess the kind of haematological abnormalities that are present in patients with mitochondrial disorders (MIDs) and the frequency of their occurrence. METHODS: The blood cell counts of a cohort of patients with syndromic and non-syndromic MIDs were retrospectively reviewed. MIDs were classified as 'definite', 'probable' or 'possible' according to clinical presentation, instrumental findings, immunohistological findings on muscle biopsy, biochemical abnormalities of the respiratory chain and/or the results of genetic studies. Patients who had medical conditions other than MID that account for the haematological abnormalities were excluded. RESULTS: A total of 46 patients ('definite' = 5; 'probable' = 9; 'possible' = 32) had haematological abnormalities attributable to MIDs. The most frequent haematological abnormality in patients with MIDs was anaemia. 27 patients had anaemia as their sole haematological problem. Anaemia was associated with thrombopenia (n = 4), thrombocytosis (n = 2), leucopenia (n = 2), and eosinophilia (n = 1). Anaemia was hypochromic and normocytic in 27 patients, hypochromic and microcytic in six patients, hyperchromic and macrocytic in two patients, and normochromic and microcytic in one patient. Among the 46 patients with a mitochondrial haematological abnormality, 78.3% had anaemia, 13.0% had thrombopenia, 8.7% had leucopenia and 8.7% had eosinophilia, alone or in combination with other haematological abnormalities. CONCLUSION: MID should be considered if a patient's abnormal blood cell counts (particularly those associated with anaemia, thrombopenia, leucopenia or eosinophilia) cannot be explained by established causes. Abnormal blood cell counts may be the sole manifestation of MID or a collateral feature of a multisystem problem.
Authors: Manuela Tumino; Concetta Meli; Piero Farruggia; Milena La Spina; Maura Faraci; Cinzia Castana; Vincenzo Di Raimondo; Marivana Alfano; Annarita Pittalà; Luca Lo Nigro; Giovanna Russo; Andrea Di Cataldo Journal: Am J Med Genet A Date: 2011-10-19 Impact factor: 2.802
Authors: J L Van Hove; S Shanske; F Ciacci; S Ballinger; J S Shoffner; D C Wallace; T Hanioka; K Folkers; E H Bossen; P S Kussin Journal: Am J Med Genet Date: 1994-06-01
Authors: P G Barth; C Van den Bogert; P A Bolhuis; H R Scholte; A H van Gennip; R B Schutgens; A G Ketel Journal: J Inherit Metab Dis Date: 1996 Impact factor: 4.982
Authors: Yuanjiu Lei; Camila Guerra Martinez; Sylvia Torres-Odio; Samantha L Bell; Christine E Birdwell; Joshua D Bryant; Carl W Tong; Robert O Watson; Laura Ciaccia West; A Phillip West Journal: Sci Adv Date: 2021-05-26 Impact factor: 14.136